These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7073948)

  • 21. An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
    Twentyman PR; Workman P
    Br J Cancer; 1983 Feb; 47(2):187-94. PubMed ID: 6824566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neurotoxicity of radiosensitizing drugs: a biochemical assessment of desmethylmisonidazole (DMM) in the rat.
    Rose GP; Taylor JM
    Toxicology; 1985 Jan; 34(1):43-56. PubMed ID: 3918357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM; Dionet C; Brown JM
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylcholinesterase and cholinesterase activities in the mouse cerebellum following misonidazole treatment.
    Clarke C; Hobbiger F; Sheldon PW
    Eur J Pharmacol; 1981 Jan; 69(2):209-11. PubMed ID: 7202519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A biochemical assessment of the neurotoxicity of the radiosensitizing drug misonidazole in the rat.
    Rose GP; Dewar AJ; Moffett BJ; Stratford IJ
    Clin Toxicol; 1981 Dec; 18(12):1411-26. PubMed ID: 6277552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.
    Hinchliffe M; McNally NJ; Stratford MR
    Br J Cancer; 1983 Sep; 48(3):375-83. PubMed ID: 6615699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic interaction of BCNU and misonidazole in humans.
    Urtasun RC; Tanasichuk H; Fulton D; Raleigh J; Rabin HR; Turner R; Koziol D; Agboola O
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):381-6. PubMed ID: 7107356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of nitroimidazoles on glucose utilization and lactate accumulation in mouse brain.
    Chao CF; Subjeck JR; Brody H; Shen J; Johnson RJ
    Radiat Res; 1984 Jan; 97(1):87-96. PubMed ID: 6695046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the sensitisation of skin radionecrosis in mice by misonidazole at low doses.
    Hendry JH; Sutton ML
    Br J Radiol; 1984 Jun; 57(678):507-14. PubMed ID: 6722448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP; Hirst DG; Brown JM
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of misonidazole during continuous low dose rate irradiation.
    Fu KK; Hurst S; Begg AC; Brown JM
    Cancer Clin Trials; 1980; 3(3):257-65. PubMed ID: 7438323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of misonidazole on some physiologic parameters in mice.
    Conroy PJ; von Burg R; Passalacqua W; Sutherland RM
    J Pharmacol Exp Ther; 1980 Jan; 212(1):47-52. PubMed ID: 7351625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative distribution of misonidazole and its amine metabolite in female Swiss Webster mice.
    Born JL; Hadley WM
    Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1157-61. PubMed ID: 3997598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotoxicity of radiation sensitizers in the mouse.
    Clarke C; Dawson KB; Sheldon PW; Ahmed I
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):787-9. PubMed ID: 7107415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recent advances in hypoxic cell radiosensitizer].
    Ono K; Takahashi M; Nishidai T; Shibamoto Y; Abe M
    Gan No Rinsho; 1983 Oct; 29(13):1608-12. PubMed ID: 6230470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of vitamin B6 on the neurotoxicity and pharmacology of desmethylmisonidazole and misonidazole: clinical and laboratory studies.
    Coleman CN; Hirst VK; Brown DM; Halsey J
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1381-6. PubMed ID: 6469761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between misonidazole and hyperthermia in EMT6 spheroids.
    Morgan JE; Bleehen NM
    Br J Cancer; 1981 Dec; 44(6):810-8. PubMed ID: 7326192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of acrylamide on beta-glucuronidase and acid phosphatase activities in rat sciatic nerve above and below a ligature.
    Cavanagh JB; Nolan CC
    Neuropathol Appl Neurobiol; 1982; 8(6):465-76. PubMed ID: 7162559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
    Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T
    Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.